BDRX
Biodexa Pharmaceuticals Plc

12,103
Loading...
Loading...
Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13

Frequently Asked Questions

What is Market Cap of Biodexa Pharmaceuticals Plc - ADR?
What is the 52-week high for Biodexa Pharmaceuticals Plc - ADR?
What is the 52-week low for Biodexa Pharmaceuticals Plc - ADR?
What is Biodexa Pharmaceuticals Plc - ADR stock price today?
What was Biodexa Pharmaceuticals Plc - ADR stock price yesterday?
What is the PE ratio of Biodexa Pharmaceuticals Plc - ADR?
What is the Price-to-Book ratio of Biodexa Pharmaceuticals Plc - ADR?
What is the 50-day moving average of Biodexa Pharmaceuticals Plc - ADR?
How many employess does Biodexa Pharmaceuticals Plc - ADR has?

Latest BDRX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.